Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)

NCT04993586 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

422

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Lower Respiratory Infection

Interventions

BIOLOGICAL: AG0302-COVID19 for Intramuscular Injection
BIOLOGICAL: AG0302-COVID19 for Intramuscular Injection
BIOLOGICAL: AG0302-COVID19 for Intramuscular Injection
BIOLOGICAL: AG0302-COVID19 for Intradermal Injection
BIOLOGICAL: AG0302-COVID19 for Intradermal Injection

Sponsor

AnGes, Inc.

Collaborators

[object Object]